Developer docs
API playgroundTry for free, no card

Search company profiles

Limbus AI

Full company profile

uuid0009ahx

Namestring
Limbus AI
Websiteurl
limbus.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Limbus AI is a Regina, Canada-based medical AI company that develops Limbus Contour, an on-premise deep learning auto-segmentation platform for radiation therapy treatment planning. The software processes CT and MR images on existing clinical workstations to automatically generate contours of organs at risk (OARs) and clinical target volumes (CTVs), supporting 260+ structures across Head & Neck, Thorax/Abdomen, and Pelvis anatomical sites. A zero-click automation workflow detects the treatment site, applies the appropriate clinical template, and exports compliant DICOM RT-Structure files to any treatment planning system without cloud transfer or GPU requirements, enabling typical contouring times of under 3 minutes on CPU and under 1 minute on GPU.

The company sells software licenses primarily to hospital radiation oncology departments, cancer centers, and clinics across Canada, the United States, the United Kingdom, Germany, Switzerland, and France, with documented customer outcomes including 55-75% reductions in dosimetrist and physician contouring time and 80% time savings for Head & Neck cases specifically. Marketing is research-driven, relying on peer-reviewed publications, webinars featuring medical physicists and radiation oncologists, and conference participation at ASTRO, ESTRO, and CARO rather than paid channels. Customer logos span academic centers (Universitätsspital Basel), regional hospitals (Pius Hospital Oldenburg, Asklepios Clinic Hamburg), and national health systems (Royal Devon and Exeter NHS Foundation Trust, BC Cancer).

On April 30, 2024, Limbus AI was acquired by Radformation, Inc., a US-based leader in cancer care automation, and now operates as a privately-held subsidiary. Limbus Contour was subsequently unified with Radformation's AutoContour into AutoContour v2.7, a single AI-driven contouring platform combining zero-click automation with seamless treatment planning system integration. The company had 1-10 employees at acquisition and had received a 2019 seed investment from Cultivator; revenue figures have not been publicly disclosed.

Short descriptiontext

Limbus AI develops on-premise deep learning auto-segmentation software that automatically contours anatomical structures for radiation therapy treatment planning, serving hospital radiation oncology departments and cancer centers across North America and EMEA. Acquired by Radformation in April 2024.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRegina, Canada
HQ citystring
Regina
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
radiation oncology software, auto-contouring software, deep learning segmentation, radiotherapy planning, medical imaging AI
Industry5 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Scientific Research and Development Services5417
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Computer Integrated Systems Design7373
  • Services-Prepackaged Software7372
Product category
Radiation Oncology Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Licensing
TypeSubscription Recurring
Description

The company sells software licenses for its Limbus Contour auto-contouring product. Software is installed on existing clinical workstations. The model implies either subscription or perpetual licensing with annual support/maintenance components.

limbus.ai
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Limbus AI develops and sells Limbus Contour, a deep learning-based auto-segmentation software for radiation therapy treatment planning. The software processes CT and MRI images locally on clinical workstations to automatically generate organs-at-risk (OAR) and clinical target volume (CTV) contours, exporting them as DICOM RT-Structure files compatible with any treatment planning system. It runs without cloud connectivity or GPU requirements and includes 260+ clinically validated anatomical structures ready for immediate clinical use.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 5-10x faster than manual contouring
+7 more records
Product overview1 text field

Limbus AI provides a unified product portfolio for AI-driven automatic contouring in radiation therapy. The core offering is Limbus Contour, an on-premises auto-segmentation solution that processes medical images locally to generate contours for radiotherapy planning. In 2024, following acquisition by Radformation, Limbus Contour was unified with Radformation's AutoContour into AutoContour v2.7 — a single AI-driven contouring platform that delivers fast, consistent, and scalable contouring across imaging modalities. The product features an extensive library of 260+ clinically validated anatomical structures (organs at risk and clinical target volumes) and operates entirely on local workstations with no cloud data transfer required.

Product and service2 records
1Limbus Contour
CategoryRadiation Oncology Software
Description

Automatic contouring software for radiation therapy that generates clinical-grade contours using deep learning segmentation. Processes CT and MRI images locally on clinical workstations, exports DICOM RT-Structure files, and integrates with treatment planning systems without requiring cloud connectivity or GPU hardware. Used by radiation oncologists, medical physicists, and dosimetrists in hospitals and cancer centers.

2AutoContour v2.7
CategoryRadiation Oncology Software
Description

Unified AI-driven contouring platform that combines AutoContour and Limbus Contour into a single product. Delivers fast, consistent, and scalable contouring across imaging modalities through zero-click automation or seamless TPS integration, reducing variability and accelerating the path from image to plan. Available to radiation oncology customers following Radformation's acquisition of Limbus AI.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

France-based company providing AI auto-segmentation for radiation oncology workflows, including atlas-free deep-learning contouring across multiple anatomical sites — a close functional match to Limbus Contour.

2MIM Software
TypeEmerging player
Description

US medical imaging AI vendor with radiation oncology and contouring capabilities (MIM Assistant, MIM Symphony). Smaller than the TPS incumbents but well established in nuclear medicine and RT segmentation workflows.

TypeDirect peer
Description

Swedish developer of radiation therapy treatment planning software (RayStation) and increasingly AI-enabled planning tools. Competes for the same RT department budgets and increasingly bundles auto-segmentation capabilities.

TypeDirect peer
Description

Finland-based AI auto-contouring vendor specifically focused on radiation therapy planning. Ships deep-learning-based OAR and target segmentation directly competing with Limbus Contour for the same radiation oncology customers.

TypeBroad incumbent
Description

Largest radiation therapy systems vendor globally; ships AI contouring as part of Ethos adaptive RT and Eclipse TPS. Represents the most direct bundling threat to Limbus's standalone positioning.

TypeOthers
Description

Acquired Limbus AI in April 2024 and now incorporates Limbus Contour into its AutoContour v2.7 platform. Included as a peer/adjoining platform given the now-overlapping product portfolio and shared radiation oncology customer base.

TypeDirect peer
Description

UK-headquartered medical imaging AI company with a strong installed base in radiation oncology, offering AI-driven auto-contouring and treatment planning integrations that directly overlap with Limbus's RT contouring niche.

TypeBroad incumbent
Description

Through AI-Rad Companion, Siemens offers AI-driven organ and contour segmentation for CT and MR imaging; competes indirectly by extending imaging-vendor AI into radiation therapy workflows.

TypeBroad incumbent
Description

Sells radiation oncology planning and image-guided therapy software with AI-driven auto-contouring modules; an established incumbent that competes for the same hospital procurement budgets.

TypeBroad incumbent
Description

Major radiation therapy hardware and software vendor with a growing portfolio of AI-assisted planning and contouring tools integrated into its treatment planning ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Limbus AI

Radiation Oncology Softwarelimbus.ai

Limbus AI develops on-premise deep learning auto-segmentation software that automatically contours anatomical structures for radiation therapy treatment planning, serving hospital radiation oncology departments and cancer centers across North America and EMEA. Acquired by Radformation in April 2024.

What Limbus AI does

Limbus AI is a Regina, Canada-based medical AI company that develops Limbus Contour, an on-premise deep learning auto-segmentation platform for radiation therapy treatment planning. The software processes CT and MR images on existing clinical workstations to automatically generate contours of organs at risk (OARs) and clinical target volumes (CTVs), supporting 260+ structures across Head & Neck, Thorax/Abdomen, and Pelvis anatomical sites. A zero-click automation workflow detects the treatment site, applies the appropriate clinical template, and exports compliant DICOM RT-Structure files to any treatment planning system without cloud transfer or GPU requirements, enabling typical contouring times of under 3 minutes on CPU and under 1 minute on GPU.

The company sells software licenses primarily to hospital radiation oncology departments, cancer centers, and clinics across Canada, the United States, the United Kingdom, Germany, Switzerland, and France, with documented customer outcomes including 55-75% reductions in dosimetrist and physician contouring time and 80% time savings for Head & Neck cases specifically. Marketing is research-driven, relying on peer-reviewed publications, webinars featuring medical physicists and radiation oncologists, and conference participation at ASTRO, ESTRO, and CARO rather than paid channels. Customer logos span academic centers (Universitätsspital Basel), regional hospitals (Pius Hospital Oldenburg, Asklepios Clinic Hamburg), and national health systems (Royal Devon and Exeter NHS Foundation Trust, BC Cancer).

On April 30, 2024, Limbus AI was acquired by Radformation, Inc., a US-based leader in cancer care automation, and now operates as a privately-held subsidiary. Limbus Contour was subsequently unified with Radformation's AutoContour into AutoContour v2.7, a single AI-driven contouring platform combining zero-click automation with seamless treatment planning system integration. The company had 1-10 employees at acquisition and had received a 2019 seed investment from Cultivator; revenue figures have not been publicly disclosed.

Limbus AI firmographics

Firmographics
Name
Limbus AI
Website
https://limbus.ai
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
11–50 employees
Short description
Limbus AI develops on-premise deep learning auto-segmentation software that automatically contours anatomical structures for radiation therapy treatment planning, serving hospital radiation oncology departments and cancer centers across North America and EMEA. Acquired by Radformation in April 2024.
Ownership category
akta.pro rank

Limbus AI industry classification

Industry
Product category
Radiation Oncology Software
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Computer Integrated Systems Design (7373), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Radiation oncology software
  • Auto-contouring software
  • Deep learning segmentation
  • Radiotherapy planning
  • Medical imaging AI

Where Limbus AI is headquartered

Location

Headquarters

HQ city
Regina
HQ country
Canada
HQ region
North America

Markets served

Limbus AI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Software Licensing: The company sells software licenses for its Limbus Contour auto-contouring product. Software is installed on existing clinical workstations. The model implies either subscription or perpetual licensing with annual support/maintenance components.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Limbus AI product offering

Product offering

Core offering

Limbus AI develops and sells Limbus Contour, a deep learning-based auto-segmentation software for radiation therapy treatment planning. The software processes CT and MRI images locally on clinical workstations to automatically generate organs-at-risk (OAR) and clinical target volume (CTV) contours, exporting them as DICOM RT-Structure files compatible with any treatment planning system. It runs without cloud connectivity or GPU requirements and includes 260+ clinically validated anatomical structures ready for immediate clinical use.

Product overview

Limbus AI provides a unified product portfolio for AI-driven automatic contouring in radiation therapy. The core offering is Limbus Contour, an on-premises auto-segmentation solution that processes medical images locally to generate contours for radiotherapy planning. In 2024, following acquisition by Radformation, Limbus Contour was unified with Radformation's AutoContour into AutoContour v2.7 — a single AI-driven contouring platform that delivers fast, consistent, and scalable contouring across imaging modalities. The product features an extensive library of 260+ clinically validated anatomical structures (organs at risk and clinical target volumes) and operates entirely on local workstations with no cloud data transfer required.

Differentiator

Problem solved

Functional benefit

Products and services

  • Limbus Contour Automatic contouring software for radiation therapy that generates clinical-grade contours using deep learning segmentation. Processes CT and MRI images locally on clinical workstations, exports DICOM RT-Structure files, and integrates with treatment planning systems without requiring cloud connectivity or GPU hardware. Used by radiation oncologists, medical physicists, and dosimetrists in hospitals and cancer centers.
  • AutoContour v2.7 Unified AI-driven contouring platform that combines AutoContour and Limbus Contour into a single product. Delivers fast, consistent, and scalable contouring across imaging modalities through zero-click automation or seamless TPS integration, reducing variability and accelerating the path from image to plan. Available to radiation oncology customers following Radformation's acquisition of Limbus AI.

Quantifiable outcome

  • 5-10x faster than manual contouring
  • +7 more outcomes

Companies that use Limbus AI

Customer profile

Named customers11 records

Segments1 record

Ideal customer profiles1 record

Limbus AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Limbus AI partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Limbus AI competitors and assessment

Company assessment

Direct peers

  • Therapanacea: France-based company providing AI auto-segmentation for radiation oncology workflows, including atlas-free deep-learning contouring across multiple anatomical sites — a close functional match to Limbus Contour.
  • RaySearch Laboratories: Swedish developer of radiation therapy treatment planning software (RayStation) and increasingly AI-enabled planning tools. Competes for the same RT department budgets and increasingly bundles auto-segmentation capabilities.
  • MVision AI: Finland-based AI auto-contouring vendor specifically focused on radiation therapy planning. Ships deep-learning-based OAR and target segmentation directly competing with Limbus Contour for the same radiation oncology customers.
  • Mirada Medical: UK-headquartered medical imaging AI company with a strong installed base in radiation oncology, offering AI-driven auto-contouring and treatment planning integrations that directly overlap with Limbus's RT contouring niche.

Emerging players

  • MIM Software: US medical imaging AI vendor with radiation oncology and contouring capabilities (MIM Assistant, MIM Symphony). Smaller than the TPS incumbents but well established in nuclear medicine and RT segmentation workflows.

Broad incumbents

  • Varian (a Siemens Healthineers company): Largest radiation therapy systems vendor globally; ships AI contouring as part of Ethos adaptive RT and Eclipse TPS. Represents the most direct bundling threat to Limbus's standalone positioning.
  • Siemens Healthineers (AI-Rad Companion): Through AI-Rad Companion, Siemens offers AI-driven organ and contour segmentation for CT and MR imaging; competes indirectly by extending imaging-vendor AI into radiation therapy workflows.
  • Brainlab: Sells radiation oncology planning and image-guided therapy software with AI-driven auto-contouring modules; an established incumbent that competes for the same hospital procurement budgets.
  • Elekta: Major radiation therapy hardware and software vendor with a growing portfolio of AI-assisted planning and contouring tools integrated into its treatment planning ecosystem.

Others

  • Radformation: Acquired Limbus AI in April 2024 and now incorporates Limbus Contour into its AutoContour v2.7 platform. Included as a peer/adjoining platform given the now-overlapping product portfolio and shared radiation oncology customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Limbus AI social profiles

Digital presence

Limbus AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Limbus AI leadership team

Management profile

Number of profiles

Profiles2 records

Limbus AI funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Limbus AI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Limbus AI

What does Limbus AI do?

Limbus AI develops and sells Limbus Contour, a deep learning-based auto-segmentation software for radiation therapy treatment planning. The software processes CT and MRI images locally on clinical workstations to automatically generate organs-at-risk (OAR) and clinical target volume (CTV) contours, exporting them as DICOM RT-Structure files compatible with any treatment planning system. It runs without cloud connectivity or GPU requirements and includes 260+ clinically validated anatomical structures ready for immediate clinical use.

Is Limbus AI a public or private company?

Limbus AI is a private company. It is classified as corporate owned and is currently acquired.

When was Limbus AI founded?

Limbus AI was founded in 2017. It employs 11 to 50 people.

Where is Limbus AI based?

Limbus AI is headquartered in Regina, Canada, in the North America region.

How does Limbus AI make money?

One revenue line is on record: software Licensing.

Who are Limbus AI's main competitors?

Direct peers on record are Therapanacea, RaySearch Laboratories, MVision AI and Mirada Medical. MIM Software is listed as an emerging player. Broad incumbents are Varian (a Siemens Healthineers company), Siemens Healthineers (AI-Rad Companion), Brainlab and Elekta. Radformation is listed as an others.

Does Limbus AI have an API?

No public API is recorded for Limbus AI.

What industry is Limbus AI in?

Limbus AI's product category is Radiation Oncology Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Imaging Technology NewsRadformation to Accelerate AI-Based Solutions with Limbus AI AcquisitionRadformation, Inc. has acquired privately-held Limbus AI, a leading global provider of automated contouring software for radiation therapy, to expand its AI-driven capabilities in cancer care. The merger combines both companies' platforms to create an advanced AI-driven contouring solution, uniting Radformation's products used in over 1,600 clinics across 28 countries with Limbus' technology impacting 500,000 patients across 400 centers worldwide. The combined entity aims to accelerate innovation and enhance patient outcomes in radiation therapy.Imaging Technology NewsRefleXion and Limbus AI Announce Technology Integration to Expedite Cancer Treatment PlanningRefleXion Medical and Limbus AI announced a licensing agreement to integrate Limbus Contour automated software into the RefleXion X1 radiotherapy treatment planning system. This integration aims to reduce contouring time by up to 80%, addressing a major bottleneck in cancer treatment planning caused by manual delineation of tumor targets. The partnership leverages RefleXion's high-resolution imaging to enhance the accuracy and precision of Limbus AI's deep-learning segmentation algorithms.PR NewswireAccuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual MeetingAccuray Incorporated announced the unveiling of Cenos, an online adaptive therapy solution for its Radixact System, at the 2023 ASTRO Annual Meeting in San Diego, in partnership with Limbus AI. The solution, currently 510(k) pending and not yet available for sale, enables medical teams to make real-time adjustments to treatment plans while patients remain on the treatment table. Limbus AI's automated contouring technology Limbus Contour, already adopted by over 250 clinics globally, will be embedded into Cenos to streamline the planning process and make online adaptive radiotherapy more accessible to clinics of all sizes.BioSpaceAccuray and Limbus AI Inc. Partner to Leverage Limbus’ Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy SolutionsAccuray and Limbus AI announced a partnership to integrate Limbus' AI-driven autocontouring algorithms into Accuray's adaptive radiotherapy solutions. The integration aims to streamline treatment planning and increase operational efficiency, with an integrated offering expected to be available starting in 2023.PR NewswireAccuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy SolutionsAccuray Incorporated and Limbus AI Inc. announced a partnership on June 2, 2022, to integrate Limbus' AI-driven autocontouring algorithms into Accuray's adaptive radiotherapy capabilities. The technology aims to automate the contouring step in treatment planning, which currently accounts for a significant proportion of personnel time and labor in plan adaptation. An integrated offering combining both technologies is expected to be made available beginning in 2023.